Initiate Clinical Study for GBR 1342, Second Investigational New Drug from Immuno-Oncology Portfolio General Announcement Filing viewer · member access Original SGX announcement
Full Yearly Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
Receives tentative ANDA approval for Dabigatran Etexilate Capsules 75 mg 110 mg & 150 mg General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives FDA Clearance of IND for GSP 304 General Announcement Filing viewer · member access Original SGX announcement
US$170,000,000 2% Resettable Onward Starting Equity-linked Securities due 2022 Debt - Listing Confirmation Filing viewer · member access Original SGX announcement